ID: MRFR/HC/6647-HCR | February 2021 | Region: Global | 95 pages
The Extracorporeal Membrane Oxygenation Machine Market was valued USD 267.60 million in 2018 and expected to register a CAGR of 4.8% during the forecast period of 2019 to 2025.
Extracorporeal membrane oxygenation is a machine that provides cardiac and respiratory support for those patients whose heart and lungs are unable to provide an adequate supply of gas exchange to the body. It is also known as a life support machine. People who are suffering from a severe and life-threatening illness needs extracorporeal membrane oxygenation machine to carry out proper functioning of heart and lungs. The global extracorporeal membrane oxygenation machine market is driven by factors such as the growing prevalence of cardiovascular and respiratory diseases, rising adoption of the ECMO machine for lung transplantation, and the growing number of ECMO centers. Additionally, the rising prevalence of lung diseases coupled with increasing geriatric population is anticipated to fuel the market growth. As there is an increasing prevalence of lung and heart diseases, the demand for extracorporeal membrane oxygenation machine is also rising nowadays. As per the survey carried out by World Health Organization in 2017, around 306 hospitals in the US have ECMO machine for treatment of heart and lung diseases that are around 9385 ECMO devices were administered in US hospitals in 2017.
On the other hand, the complications associated with extracorporeal membranes oxygenation machines such as bleeding, infections, and technical failures are projected to hamper the growth of the market during the assessment period.
The extracorporeal membrane oxygenation machine market has been segmented based on component, modality, application, and region.
The market, based on component, has been divided into pumps, oxygenators, controllers, cannula,
and accessories. The oxygenators segment is expected to hold a major share in the market due to the rising prevalence of lung diseases and increasing adoption of extracorporeal membrane oxygenation machine for cardiac treatments. The pumps segment is anticipated to be the fastest-growing as these are most widely used in the treatment of asthma.
The extracorporeal membrane oxygenation machine market based on modality is further segmented into veno-arterial (VA), veno-venous (VV), and arterio-venous (AV). The veno-arterial segment is expected to hold a major share in the market due to its widespread use in the treatment of cardiovascular collapse. Whereas veno-venous segment is expected to be the fastest-growing due to its increasing use in cardiogenic shock.
The market based on application is further segmented into respiratory, cardiac, and extracorporeal cardiopulmonary resuscitation (ECPR). The respiratory segment is expected to hold the major share in the market due to its crucial role in supporting pulmonary function and is projected to witness lucrative growth over the forecast period whereas the extracorporeal cardiopulmonary resuscitation segment is expected to be the fastest-growing due to the rising incidence of cardiac illness worldwide.
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The extracorporeal membrane oxygenation machine market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European extracorporeal membrane oxygenation machine market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe. The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been divided into the Middle East and Africa.
Regional Market Summary
Global Extracorporeal Membrane Oxygenation Machine Market Share, by Region, 2018 (%)
Source: World Health Organization (WHO)
The market in the Americas is expected to dominate the global extracorporeal membrane oxygenation machine market due to the rising incidence of lung cancer, favorable reimbursement scenario, and increasing investment in research and development of new medical devices. As there is a rising prevalence of lung cancer in the US, the demand for extracorporeal membrane oxygenation machine is also increasing in this region. As per the survey carried out by the America Lung Association in 2017, around 11 million people are diagnosed with COPD in the US every year. High cases of COPD in the US and Canada is expected to drive the market growth.
The extracorporeal membrane oxygenation machine market in Europe showed a substantial amount of growth. This can be attributed to the presence of a well-established healthcare system, an increase in chronic diseases, and the involvement of key companies. As per the Luce Report on Lung Cancer 2016, around 312,000 people in Europe have lung cancer. As there is an increasing prevalence of lung cancer in this region, the demand for extracorporeal membrane oxygenation machine is also growing. Therefore, the market is expected to grow during the forecast period.
The market in Asia-Pacific is projected to be the fastest-growing over the forecast period owing to the rising prevalence of lung cancer in countries such as India and China. According to National Cancer Center (NCC) Report 2018, out of a total population around 35.1%, people are diagnosed with lung cancer every year in China and is one of the leading cause of deaths in this country.
The market in the Middle East & Africa is projected to account for the least share of the global extracorporeal membrane oxygenation machine market due to low disposable income in the region.
Extracorporeal Membrane Oxygenation Machine Market, by Component
Extracorporeal Membrane Oxygenation Machine Market, by Modality
Extracorporeal Membrane Oxygenation Machine Market, by Application
Global Extracorporeal Membrane Oxygenation Machine Market, by Region
|Market Size||2025: Significant Value|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Component, Modality, Application|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Getinge Group, Medtronic, Livanova PLC, Abbott, Agilent Technologies, Siemens AG, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, Microport Scientific Corporation, Nipro Corporation, ALung Technologies, Inc., MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Terumo Cardiovascular Systems Corp|
|Key Market Opportunities||Increasing investment in research and development of new medical devices|
|Key Market Drivers||The increasing prevalence of cardiovascular concerns|
Frequently Asked Questions (FAQ) :
global market was valued at 267.6 million in 2018.
Extracorporeal Membrane Oxygenation Machine (ECMO) Marketis expected to exhibit a solid 4.8% CAGR over the forecast period from 2019 to 2025.
The increasing prevalence of cardiovascular concerns is the major driver for the global extracorporeal membrane oxygenation machine market.
The Americas market is expected to hold the largest share in the market.
Leading players in the extracorporeal membrane oxygenation machine market include Getinge Group, Agilent, Abbott, and Siemens, among others.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.